The World Drug Safety Congress Europe organizing a congress in Amsterdam, that encouraging patients, doctors, and pharmaceutical and biotech companies to have more ability to make the best choices about drug safety. Also, 700+ PV specialists will be gathered by Drug Safety Congress Europe.
Examining benefit-risk management techniques, patient-centric methods, as well as the use of big data, and AI in pharmacovigilance, and talking about how you may meet the obstacles posed by social media and international drug safety regulations will be the main topics of the event
As PharmaSoft, since we attach great importance to digitalization in terms of fulfilling both regulatory affairs and pharmacovigilance processes with a zero-error policy, the congress is a great chance to make more progress in the area of PV.
The topics that will be covered during the congress are listed below:
- How to plan for the wider international drug safety landscape
- How to work compliantly with a global regulatory overview and recent developments
- How to establish a robust approach to safety in oncology and advanced therapies
- How to harness Big Data and emerging technologies such as AI to support your safety measures
- How to manage drug safety operations in light of increasing complexities
- How to manage data and electronic submissions better
- How to effectively process the volume of cases
- How to operate within financial and logistical constraints
If you would like to share your industry experiences on our page, you can send your articles to our editor via atelier@pharmasoft.com.tr.
Don’t forget to subscribe to be notified instantly about our new posts!
See you again very soon, stay healthy,
PharmaSoft Atelier
